Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Badoglio

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|December 12, 2018
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis]Helène Zephir, Mathieu Puyade, Antoine Gueguen, et al.
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.
Bone Marrow Transplantation|October 24, 2021
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based studyMassimo Martino, Annalisa Pitino, Mercedes Gori, et al.
Journal of Autoimmunity|March 31, 2023
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseasesRaffaella Greco, John A Snowden, Nina Simone Knelange, et al.
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 3, 2016
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation RegistryMassimo Martino, Francesco Lanza, Lorenzo Pavesi, et al.
Frontiers in Immunology|April 17, 2020
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)Robert David Sandler, Rachel Scarlett Tattersall, Helene Schoemans, et al.
Bulletin Du Cancer|October 17, 2020
[Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Xavier Treton, Laurent Alric, et al.
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|December 12, 2018
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis]Helène Zephir, Mathieu Puyade, Antoine Gueguen, et al.
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.
Bone Marrow Transplantation|October 24, 2021
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based studyMassimo Martino, Annalisa Pitino, Mercedes Gori, et al.
Journal of Autoimmunity|March 31, 2023
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseasesRaffaella Greco, John A Snowden, Nina Simone Knelange, et al.
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 3, 2016
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation RegistryMassimo Martino, Francesco Lanza, Lorenzo Pavesi, et al.
Frontiers in Immunology|April 17, 2020
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)Robert David Sandler, Rachel Scarlett Tattersall, Helene Schoemans, et al.
Bulletin Du Cancer|October 17, 2020
[Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Xavier Treton, Laurent Alric, et al.
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Pageof 5